| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |